Objectives To identify factors associated with delayed antimicrobial treatment in febrile children with urinary tract infection (UTI).
U rinary tract infections (UTIs) are a frequently occurring bacterial infection in young children; 8.4% of girls and 1.7% of boys will have a UTI within the first 6 years of life. 1 The long-term goal of managing UTIs is to prevent permanent renal scarring. Delayed treatment of febrile UTIs is associated with greater rates of acquired renal scarring. 2 The primary objective of this study was to identify factors associated with delayed antimicrobial treatment in children with febrile UTIs.
Methods
To evaluate the question posed in this study, we used data from 2 prospective, longitudinal studies of children with UTI, Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) and Careful Urinary Tract Infection Evaluation (CUTIE), conducted in 2007-2011 and 2008-2011 , respectively. The children in these studies were 2-72 months old and presented following their first or second UTI at primary and subspecialty care settings throughout the US. The methodology of these studies has been reported previously. 3, 4 To summarize, children with vesicoureteral reflux were enrolled in the RIVUR trial (n = 607), whereas those without vesicoureteral reflux were enrolled in the parallel CUTIE study (n = 195). Not all sites participating in the RIVUR trial participated in the CUTIE study. Data-collection forms in both studies were identical with a few exceptions. Institutional review boards at all participating sites approved the RIVUR and CUTIE study protocols. From these datasets, we extracted the data on the following variables: age, sex, history of UTI, ethnicity, child's race, primary caregiver's education level, insurance, income, household size, and duration of fever before the initiation of antimicrobial therapy. Income was reported and analyzed as a categorical variable (<$13 500, $13 500-23 499, $23 500-33 499, $33 500-57 999, $58 000-99 999, $100 000-149 999, and >$150 000). We included race, ethnicity, caregiver's education level, and income because these factors were found to be associated with delayed treatment in studies in adults (with conditions other than UTI). [5] [6] [7] [8] [9] Insurance was included based unequal access to care could potentially be related to treatment delay. 
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At the time of enrollment in the CUTIE and RIVUR studies, parents were asked about the duration of their child's fever (in hours as a continuous variable) before the initiation of antimicrobial therapy for the UTI. We defined treatment delay as the number of hours between the onset of fever and the start of antimicrobial therapy. As this was our main outcome measure, we excluded children who were afebrile (reported temperature ≤38°C) or in whom duration of fever was missing.
We categorized each patient as "poor" or "not poor" based on the reported family income and household size using the average poverty threshold recommended by the Census Bureau during the study period (2007) (2008) (2009) (2010) (2011) .
We conducted univariate analyses to evaluate each variable's effect on treatment delay. T-test, one-way ANOVA, or linear regression was used depending on the type of variable. We then constructed a multivariable regression model with treatment delay as the dependent variable. Potential predictor variables are listed in Table I . STATA 14.0 (StataCorp LLC, College Station, Texas) was used for all analyses.
Results
Of the 802 children enrolled in the RIVUR and CUTIE studies, we excluded 113 children who were missing information about treatment delay and 29 children who were afebrile; 660 children were included in the analysis. The mean age of the study population was 17.0 months. Other characteristics of the study population can be found in Table I . Compared with children who were excluded, those included were significantly younger (mean age 17.0 months for included children vs 36.0 months for excluded children) and significantly less likely to have a previous history of UTIs (7.9% vs 20.9%). All other demographic characteristics were comparable in included and excluded patients. The mean time before the initiation of antimicrobial therapy was 56.2 hours. On univariate analysis, only age and insurance type were significantly associated with treatment delay on (P < .001 and P = .002 respectively). Older children were more likely to have delayed treatment; children <6, ≥6-11, ≥12-23, ≥24 months old had mean delay times of 30.3, 59.3, 68.5, and 72.6 hours, respectively. Treatment was delayed by an average of 26.2 hours in children ≥12 months of age compared with younger children (Figure) . When we compared commercial with noncommercial insurance types, treatment was delayed by a mean of 12.6 hours in patients with commercial insurance (Table II) .
In the multivariable model, older age and insurance status remained significantly associated with longer treatment delays even after we adjusted for sex, history of UTI, ethnicity, race, education, insurance, and income (Table III) .
Discussion
We found that febrile children with UTI who were ≥12 months of age received antimicrobial therapy 26.2 hours later than children <12 months of age. This finding is consistent with a previous study 11 and might reflect increased parental concern and urgency toward febrile illnesses in younger children. This is concerning because recent studies have found that older children with febrile UTIs may have greater rates of renal scarring compared with younger children; a study conducted on a population derived from RIVUR and CUTIE studies 2 as well as a meta-analysis 12 of 9 cohort studies also found greater rates of renal scarring in older children. Consequently, it seems important to educate physicians, parents, and triage nurses about the importance of early evaluation of children with fever, even for children >12 months of age.
We also found that children with commercial insurance had longer delays than those without commercial insurance. This is contrary to studies in adult populations and in studies from pediatric emergency departments, which found that patients who were uninsured or receiving Medicaid had increased delays compared with those with private insurance. 7, 13 Some reports suggest that, compared with patients without commercial insurance, patients with commercial insurance are less likely to seek care in an emergency department. [13] [14] [15] [16] Delayed treatment in children with commercial insurance in our study could be explained if these patients were disproportionately evaluated in private clinics, where screening tests for UTI often are sent to an off-site laboratory (compared with an emergency department, where testing occurs on site 24 hours a day). It also is possible in the private sector that providers choose to follow patients before pursuing UTI, or parents and providers desire to avoid catheterization, especially of older children. In contrast, children without commercial insurance may have been more likely to have been evaluated in an emergency department, where testing is performed onsite.
A limitation of our study is that the location where the child was first evaluated and treated for UTI (ie, emergency department vs outpatient clinic or private office) was not gathered, which prevented us from examining whether it was associated with delayed treatment. Also, duration of fever was reported by parents and thus may not be accurate. Strengths of our study include the relatively large samples size, involvement of multiple centers, and availability of data on family income and other potential confounding factors.
Older age and delayed antimicrobial treatment of febrile UTIs are associated. It is important to advise parents to seek evaluation for prompt treatment of UTIs, especially in older children. These data also should encourage providers to pursue diagnosis and rapid treatment. ■ 
